Last reviewed · How we verify

NCT04052867

Intravenous Lignocaine Infusion in Laparoscopic Donor Nephrectomy

Status unknown NA Last updated 30 April 2020
What this trial tests

NA trial testing Lignocaine in Postoperative Pain in 40 participants. Status unknown.

Timeline
17 September 2019
Primary endpoint
15 July 2021
31 July 2021

Quick facts

Lead sponsorUniversity of Malaya
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposesupportive care
Enrollment40
Start date17 September 2019
Primary completion15 July 2021
Estimated completion31 July 2021
Sites1 location across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

University of Malaya

Who can join

18 and older, any sex, with Postoperative Pain or Renal Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Administration of morphine as boluses or via a patient controlled analgesic device (PCA) has been the standard practice for donors after nephrectomy. However, administration of morphine is far from being ideal analgesic as it does not provide optimal dynamic pain relief after major surgery, consistently demonstrate little effect on surgical stress response and organ dysfunction with high incidences of postoperative nausea/vomiting, respiratory depression and sedation. Several studies demonstrated perioperative intravenous lignocaine infusion can improve post-operative pain scores and morphine consumption in abdominal surgery. The aim of this study is to identify the effectiveness of intra-operative lignocaine infusion in lowering postoperative pain and reduce postoperative morphine consumption in patients who undergo laparoscopic donor nephrectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lignocaine

Trials testing the same drug.

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other University of Malaya trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04052867.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing